Andrew J. Pulkrabek - Managing Partner
Andrew is a finance, strategy, and turn around executive with deep "blue chip" and entrepreneurial experience in developing new businesses and defining and exploiting value from current operations and technologies worldwide.
Early in his career at Patterson Companies, Andrew led the revitalization of several business units, including the turnaround of a national Group Purchase Organization (GPO) business and the post-acquisition integration and turnaround of a B2B medical consumables business. Later, serving as Director of Strategy and Corporate Development at Novartis, he drove the revitalization and above market peer growth of a 30 year old brick and mortar medical business. Andrew led the formation of a joint venture that evolved the company into a hybrid physical and online business, ultimately increasing revenues by 180% while improving performance to a 37% EBIT. After Novartis, Andrew served as CEO of the fledgling healthcare technology firm, HFT. In this role he led the company from the ground up, forming the team, raising capital, overseeing all clinical studies, and ultimately leading the company to exit. Andrew then moved into venture capital, working with Burrill & Co., a $1.5B venture capital firm.
Most recently, Andrew was the founder and developer of 43North, a private equity operation in New York where he sourced companies of all stages and from all parts of the world for investment. In his time leading the organization, he worked in India, Israel, UK, Mexico, and China. Ultimately he conducted 13 equity transactions in high-tech, med-tech, biotech, and advanced manufacturing companies from around the world.
Being a native of the Iron Range of Minnesota, Andrew returned to his home state to co-found Marabek. He saw the need for comprehensive solutions for the organic performance of existing operations in manufacturing companies, to stabilize and increase operational and financial health. At the same time, given his international experience and the geopolitical dynamics, he understands the need for inorganic growth (mergers and acquisitions) for these same companies to internalize competitive advantages through unique intellectual property and to expand their geographic reach and distribution.
Andrew has worked around the world and lived and been educated in New Zealand, Mexico, Austria, and the United States. He has served as an Adjunct Professor of law at Mitchell Hamline School of Law, guest lectured at Cambridge University, UK and Carlson School of Management. He serves as a member of the University of Minnesota Business Advisory Group for the Venture Center. Twin Cities Business listed him as one of “200 Minnesotans You Should Know”. Andrew holds a BS and an MBA from the University of Minnesota.